4 recruiting, 2 completed, 1 not yet recruiting, 1 suspended. 9 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Recruiting 4, Completed 2, Not yet recruiting 1, Suspended 1, Unknown 1 |
| Phase 1 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow THC: new trials by email Literature Review of THC trials Research Report on THC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks THC, Placebo - THC | Phase 2 | Not yet recruiting | Yale University | 50 | 2025-08-31 | 2025-06-10 |
| Pilot fMRI Studies of Aging-Related Effects of THC THC, Placebo - THC | Phase 2 | Recruiting | Yale University | 10 | 2025-07-01 | 2025-10-09 |
| Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Cannabis, Nicotine, Pax Loose Leaf Vaporizer - THC, Cannabis | Phase 2 | Recruiting | University of California, San Francisco | 48 | 2025-07-01 | 2026-01-07 |
| Modulation of THC Effects by CBD: a Dose-ranging Study ∆9-tetrahydrocannabinol - Cannabis, THC | Phase 1 / Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 100 | 2024-06-27 | 2025-12-22 |
| Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV THC, CBD - HIV, Cannabis | Phase 2 | Recruiting | University of California, San Diego | 90 | 2023-09-01 | 2026-05-01 |
| Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment THC ~2.5%, THC ~5%, THC ~10% - Migraine, Cannabis | Phase 2 | Suspended | University of California, San Diego | 20 | 2023-02-15 | 2026-03-16 |
| THC Memory & Reward Learning Pilot Marijuana, Hash, THC, or Grass, Placebo - Marijuana, THC | Phase 1 / Phase 2 | Unknown | Hartford Hospital | 20 | 2022-07-07 | 2025-03-17 |
| A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Cybis™ 10:25 THC:CBD oil - Chronic Pain, Neck Pain | Phase 1 / Phase 2 | Completed | Cymra Life Sciences | 28 | 2021-09-20 | 2022-07-07 |
| Efficacy of Inhaled Cannabis for Acute Migraine Treatment THC ~5%, CBD ~12%, THC ~5% and CBD ~12% - Migraine, Cannabis | Phase 2 | Completed | University of California, San Diego | 92 | 2020-11-20 | 2023-02-28 |
Marijuana Abuse (6) · Migraine Disorders (2) · Back Pain (1) · Chronic Pain (1) · Marijuana Smoking (1) · Memory Disorders (1) · Neck Pain (1) · Neuroinflammatory Diseases (1) · Pain (1) · Tobacco Use (1) · Vaping (1)
Chemically-Induced Disorders (6) · Mental Disorders (6) · Substance-Related Disorders (6) · Nervous System Diseases (4) · Pathological Conditions, Signs and Symptoms (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Headache Disorders (2) · Headache Disorders, Primary (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Behavior (1) · Inflammation (1) · Marijuana Use (1) · Neurobehavioral Manifestations (1)
Dronabinol (6) · nabiximols (4) · Cannabidiol (3) · THC 5 (2) · salicylhydroxamic acid (2) · Nicotine (1)
University of California, San Diego (3) · Yale University (2) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Cymra Life Sciences (1) · Hartford Hospital (1) · University of California, San Francisco (1)
United States (7) · Australia (1) · Canada (1)
Godfrey Pearlson, M.D (2) · Nathaniel M Schuster, MD (2) · Didier Jutras-Aswad, MD, MS (1) · Gideon St Helen (1) · Jose Cortes-Briones, PhD (1) · Richard Chye (1) · Ronald J Ellis, MD, PhD (1)
R01DA056451 (1), R03DA054453 (1)